LSE:CVSG (CVS Group plc)

About CVSG

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

CVS Group plc (LSE: CVSG) Latest News

Investing Articles

These under-the-radar stocks popped in July. I think there could be more to come

Looking for stocks showing positive momentum? These two had a great last month, reveals Paul Summers.

Read more »

Investing Articles

Can this battered growth stock rise from the dead?

Paul Summers takes a look at the latest numbers from this former market star.

Read more »

Investing Articles

Why I think the Rolls-Royce share price crash could be an opportunity to make a million

Rolls-Royce Holding plc (LON: RR) could deliver an impressive turnaround.

Read more »

Investing Articles

Have £2,000 to spend? These out-of-favour growth stocks could still help you retire early

Paul Summers takes a look at two acquisition-friendly growth stocks, both of which reported to the market this morning.

Read more »

Investing Articles

3 secret stocks for low-risk investors

Paul Summers picks out three stocks with defensive characteristics that he'd buy and hold for the long term.

Read more »

Investing Articles

2 stocks I’d invest £1,000 in for retirement

These two shares could deliver high returns in the long run.

Read more »

Investing Articles

2 turnaround stocks I’d buy in 2018

These stocks have been shunned by the market in recent months but Paul Summers suspects this might be a golden…

Read more »

Growth
Investing Articles

2 soaring growth stocks I’d buy for the next 25 years

Many investors steer clear of shares that are already flying, but there shouldn't be any need to be scared of…

Read more »

Investing Articles

One growth stock I’d buy ahead of Astrazeneca plc

If dividends aren't a priority, Paul Summers think this top growth stock might be a better bet than Astrazeneca plc…

Read more »

Investing Articles

2 fast-rising growth stocks with lots of upside

Looking to invest for growth? These two shares have great momentum.

Read more »

Investing Articles

These high flyers rose more than two-thirds over the last year. Can they keep soaring?

Outpacing the main indexes, these companies have had a spectacular last 12 months. There could be more to come.

Read more »

Investing Articles

2 growth stocks owned by this Neil Woodford-beating fund

Can you afford to ignore these two hidden growth champions?

Read more »